Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
267
datasets available to search
ShareScore release 0.9.0
Dataset results
267 results for “Biliary tract cancer”
Immuno-related transcripts in biliary tract cancers
GEO Series GSE90698. Homo sapiens. 44 samples. Type: Expression profiling by array.
Observational Monocentric Study on Biliary Tract Cancer (BABEL)
ClinicalTrials.gov study NCT05942807. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vessel Resection and Reconstruction of Biliary Tract Cancers
ClinicalTrials.gov study NCT01861483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Immunotherapy Combined With Y-90 SIRT Therapy in Advanced Stage Intrahepatic Biliary Tract Cancer (BTC)
ClinicalTrials.gov study NCT04238637. IPD Sharing: NO. Countries: 1. Publications: 0.
Toripalimab With or Without Lenvatinib or Chemotherapy in First-Line Treatment of Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT06362317. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination of Gemcitabine, Oxaliplatin, Sintilimab and Bevacizumab in Unresectable Biliary Tract Cancer
ClinicalTrials.gov study NCT04984980. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Identification of Prognostic Gene Mutations in Biliary Tract Cancer Using Whole Genome Sequencing
ClinicalTrials.gov study NCT03718897. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of MRG003 in the Treatment of EGFR-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT04838964. IPD Sharing: NO. Countries: 1. Publications: 0.
Feasibility Study of Multi-Platform Profiling of Resected Biliary Tract Cancer
ClinicalTrials.gov study NCT04561453. IPD Sharing: NO. Countries: 1. Publications: 0.
The Purpose of This Trial is to Determine if Regorafenib Plus Durvalumab (MEDI4736) is Safe and Effective in Treatment of Chemo Refractory Advanced Biliary Tract Cancers
ClinicalTrials.gov study NCT04781192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 3b, Open-label, Multi-center Study on Durvalumab in Combination With Gemcitabine-based Chemotherapy as 1L Treatment for the Chinese Patients With Unresectable Biliary Tract Cancers (BTC)
ClinicalTrials.gov study NCT05924880. IPD Sharing: YES. Countries: 1. Publications: 0.
A Study of MRG002 in the Treatment of HER2-positive Unresectable, Locally Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT04837508. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase I Study of Adjuvant Chemotherapy With GS in Biliary Tract Cancer Undergoing Resection Without Major Hepatectomy
ClinicalTrials.gov study NCT01713387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety of Irinotecan Liposome Injection Combined With 5-FU/LV± Immunotherapy in First-line Gemsitabine + Immunoprogressive Patients With Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT06282120. IPD Sharing: NO. Countries: 1. Publications: 0.
Adoptive Transfer of Tumor Infiltrating Lymphocytes for Biliary Tract Cancers
ClinicalTrials.gov study NCT03801083. IPD Sharing: NO. Countries: 1. Publications: 0.
A Clinical Study of PD-L1 Antibody ZKAB001 Combined With Capecitabine in Resected Biliary Tract Cancer
ClinicalTrials.gov study NCT04608786. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers
ClinicalTrials.gov study NCT06001658. IPD Sharing: NO. Countries: 1. Publications: 0.
Varlitinib Plus Capecitabine in Chinese Patients With Advanced or Metastatic Biliary Tract Cancer
ClinicalTrials.gov study NCT03231176. IPD Sharing: NO. Countries: 1. Publications: 0.
GemCis Plus PD-1/PD-L1 Inhibitor in Advanced Biliary Tract Cancer: Efficacy and Immune Microenvironment （BTC-IM-1）
ClinicalTrials.gov study NCT06988592. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase II Study of Gemcitabine With Oxaliplatin as First Line Chemotherapy in Advanced Biliary Tract Cancer
ClinicalTrials.gov study NCT00504192. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.